INSIGHTS ON UPSTREAM MANUFACTURING
-
![FUJIFILM Biosciences - Oceo Rover webinar]( "The First On-Demand, Automated Solution For Powdered Media And Buffer Hydration")
The First On-Demand, Automated Solution For Powdered Media And Buffer HydrationDiscover how an automated, single-use hydration system cuts preparation time in half while delivering consistent, on-demand media and buffer solutions for bioprocessing operations.
-
![GettyImages-2187764040-cell-culture-testing-manufacturing-in-lab]( "Chemically Defined Medium For Intensified AAV And LV Production In HEK293 Cells")
Chemically Defined Medium For Intensified AAV And LV Production In HEK293 CellsDiscover how a chemically defined medium designed for suspension HEK293 perfusion cultures supports intensified AAV and LV production processes, with viable cell densities exceeding 10^8 cells/mL.
-
![GettyImages-2193144544-scientist-cell-culture-in-lab]( "Addressing Gaps In The CGT Market Through Partnership")
Addressing Gaps In The CGT Market Through PartnershipReducing variability is critical to advancing cell therapy development. Learn how cell sourcing, quality-focused manufacturing strategies, and ecosystem partnerships can support reproducible research.
-
![Future-Focused Customer-Centric Bioprocessing Solutions With Eppendorf]( "Future-Focused Customer-Centric Bioprocessing Solutions With Eppendorf")
Future-Focused Customer-Centric Bioprocessing Solutions With EppendorfDe-risk bioprocess scale-up with application-focused workflow validation. Discover strategies for transitioning therapies from R&D to clinical production.
-
Designing Scalable Cell Therapy For Successful Development7/23/2026
Only 49 cell and gene therapies have reached approval despite 5,000+ active clinical trials. Closing that gap requires designing for commercial-scale manufacturing from the earliest research decisions.
-
Enhancing AAV Manufacturing Yield Via Mini-Helper Plasmid7/23/2026
Learn how rational plasmid engineering and promoter optimization can significantly improve AAV productivity while reducing plasmid burden, paving the way for more efficient and scalable viral vector manufacturing.
-
Navigating AI Compliance In Life Sciences: FDA Policy Insights For AI Governance7/22/2026
Navigating life sciences AI compliance requires strong governance, expert human oversight, and transparent, low-risk deployment strategies.
-
Next-Generation Mesenchymal Stem Cells For Cancer And Regenerative Medicine7/21/2026
Researchers are advancing engineered mesenchymal stem cells using efficient non-viral gene delivery, enabling scalable, targeted therapies for solid tumors while preserving tumor-homing function and manufacturability.
UPSTREAM MANUFACTURING SOLUTIONS
-
![FUJIFILM Biosciences - Oceo Rover 2]( "What Is Oceo Rover? A Platform Solution To Deliver Consistent Solutions On Demand")
Automated buffer and media preparation is reshaping bioprocessing operations, offering over 50% time savings, reduced labor demands, and safer floor-level handling compared to traditional methods.
-
![FUJIFILM Biosciences - Oceo Rover]( "Oceo Rover: Automated Hydration System")
Learn about an automated hydration system that replaces manual powder prep with a closed-loop, single-use skid designed to cut turnaround times and reduce contamination risk in bioprocessing.
-
![FUJIFILM Biosciences - AdaptPD]( "Accelerate Development With AdaptPD CHO-MK Platform Media")
A novel CHO-MK cell culture medium and feed system designed for fed-batch biologics production, delivering titers up to 12 g/L in 4 to 7 days and 2 to 3x productivity gains over conventional methods.
-
![FUJIFILM Biosciences - BalanCD Feed 4]( "BalanCD CHO Feed 4 Evo: An Enhanced Feed for Evolving mAb Process Platforms")
Scale up mAb production with confidence using an evolved CHO feed that simplifies hydration to three steps, improves media stability, and delivers consistent titers across multiple CHO subtypes.
-
![GettyImages-1089913166-scientist-glasses-laboratory-research]( "Support Consistent Research With Defined Umbilical Cord-Derived MSCs")
Consistent MSC research starts with controlling variability. Cell sourcing and optimized cryopreservation strategies can improve process control for umbilical cord-derived cell therapy development.
